{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:42:17Z","timestamp":1785148937845,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T00:00:00Z","timestamp":1415059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00432-014-1845-6","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T08:06:37Z","timestamp":1415001997000},"page":"887-899","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase"],"prefix":"10.1007","volume":"141","author":[{"given":"Katerina","family":"Machova Polakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vojtech","family":"Kulvait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Benesova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Linhartova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Klamova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Jaruskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"de Benedittis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Baccarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Stopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hochhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Soverini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,4]]},"reference":[{"key":"1845_CR1","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","volume":"122","author":"M Baccarani","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF et al (2013) European LeukemiaNet recommendations for the management of chronic myeloid leukemia. Blood 122:872\u2013874","journal-title":"Blood"},{"key":"1845_CR2","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1099\/0022-1317-79-12-2921","volume":"79","author":"MA Bracho","year":"1998","unstructured":"Bracho MA, Moya A, Barrio E (1998) Contribution of Taq polymerase-induced errors to the estimation of RNA virus diversity. J Gen Virol 79:2921\u20132928","journal-title":"J Gen Virol"},{"key":"1845_CR3","doi-asserted-by":"crossref","first-page":"13081","DOI":"10.1073\/pnas.0801523105","volume":"105","author":"PJ Campbell","year":"2008","unstructured":"Campbell PJ, Pleasance ED, Stephens PJ, Dicks E, Rance R, Goodhead I et al (2008) Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. PNAS 105:13081\u201313086","journal-title":"PNAS"},{"key":"1845_CR4","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","volume":"293","author":"ME Gorre","year":"2001","unstructured":"Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN et al (2001) Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293:876\u2013880","journal-title":"Science"},{"key":"1845_CR5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jmoldx.2013.03.003","volume":"15","author":"V Grossmann","year":"2013","unstructured":"Grossmann V, Roller A, Klein HU, Weissmann S, Kern W, Haferlach C et al (2013) Robustness of amplicon deep sequencing underlines its utility in clinical applications. J Mol Diagn 15:473\u2013484","journal-title":"J Mol Diagn"},{"key":"1845_CR6","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1200\/JCO.2008.16.9953","volume":"26","author":"JS Khorashad","year":"2008","unstructured":"Khorashad JS, de Lavallade H, Apperley JF, Milojkovic D, Reid AG, Bua M et al (2008) Finding of kinase domain mutation in patients with chronic phase chronic myeloid leukemia responding to imatinib may identify those at high risk of disease progression. J Clin Oncol 26:4806\u20134813","journal-title":"J Clin Oncol"},{"key":"1845_CR7","doi-asserted-by":"crossref","unstructured":"Kohlmann A, Martinelli G, Alikian M, Artusi V, Auber B, Belickova M, et al (2013) The Interlaboratory Robustness Of Next-Generation Sequencing (IRON) Study Phase II: deep-sequencing analyses of hematological malignancies performed in 8,867 cases by an international network involving 27 laboratories [abstract]. 2013 annual meeting abstracts, Blood 122:743","DOI":"10.1182\/blood.V122.21.743.743"},{"key":"1845_CR8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature03959","volume":"437","author":"M Margulies","year":"2005","unstructured":"Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA et al (2005) Genome sequencing in microfabricated high-density picolitre reactors. Nature 437:376\u2013383","journal-title":"Nature"},{"key":"1845_CR9","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/leu.2009.168","volume":"23","author":"MC M\u00fcller","year":"2009","unstructured":"M\u00fcller MC, Cross NC, Erben P, Schenk T, Hanfstein B, Ernst T et al (2009) Harmonization of molecular monitoring of CML therapy in Europe. Leukemia 23:1957\u20131963","journal-title":"Leukemia"},{"key":"1845_CR10","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1200\/JCO.2011.35.0934","volume":"29","author":"WT Parker","year":"2011","unstructured":"Parker WT, Lawrence RM, Ho M, Irwin DL, Scott HS, Hughes TP et al (2011) Sensitive detection of BCR-ABL11 mutations in patients with chronic myeloid leukemia after imatinib resistance is predictive of outcome during subsequent therapy. J Clin Oncol 29:4250\u20134259","journal-title":"J Clin Oncol"},{"key":"1845_CR11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.exphem.2009.10.003","volume":"38","author":"KM Polakova","year":"2010","unstructured":"Polakova KM, Polivkova V, Rulcova J, Klamova H, Jurcek T, Dvorakova D et al (2010) Constant BCR-ABL1 transcript level\u00a0>\u00a0or\u00a0=\u00a00.1% (IS) in patients with CML responding to imatinib with complete cytogenetic remission may indicate mutation analysis. Exp Hematol 38:20\u201326","journal-title":"Exp Hematol"},{"key":"1845_CR12","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1073\/pnas.1208715109","volume":"109","author":"MW Schmitt","year":"2012","unstructured":"Schmitt MW, Kennedy SR, Salk JJ, Fox EJ, Hiatt JB, Loeb LA (2012) Detection of ultra-rare mutation by next-generation sequencing. PNAS 109:14508\u201314513","journal-title":"PNAS"},{"key":"1845_CR13","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood-2010-12-326405","volume":"118","author":"S Soverini","year":"2011","unstructured":"Soverini S, Hochhaus A, Nicolini FE, Gruber F, Lange T, Saglio G et al (2011) BCR-ABL1 kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet. Blood 118:1208\u20131215","journal-title":"Blood"},{"key":"1845_CR14","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood-2013-03-487728","volume":"122","author":"S Soverini","year":"2013","unstructured":"Soverini S, De Benedittis C, Polakova KM, Brouckova A, Horner D, Iacono M et al (2013) Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL1 kinase domain. Blood 122:1364\u20131648","journal-title":"Blood"},{"key":"1845_CR15","author":"MS Zabriskie","year":"2014","unstructured":"Zabriskie MS, Eide CA, Tantravahi SK, Vellore NA, Estrada J, Nicolini FE et al (2014) BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive Leukemia. Cancer Cell. doi: 10.1016\/j.ccr.2014.07.006","journal-title":"Cancer Cell"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1845-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-014-1845-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1845-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T10:39:34Z","timestamp":1598438374000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-014-1845-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,4]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1845"],"URL":"https:\/\/doi.org\/10.1007\/s00432-014-1845-6","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,4]]}}}